ArticleThe Journal of biological chemistry2026
LeGenD: High-throughput N-glycan profiling using explainable AI and lectin profiling.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Glycosylation affects many vital functions in organisms. Thus, their measurement is critical from basic science to biotechnology, including biopharmaceutical development and clinical diagnostics. However, the throughput and cost of conventional glycan analysis can be challenging. Lectins offer an alternative approach for analyzing glycans, but they only provide glycan epitopes and not full glycan structure information. To overcome these limitations, we developed Lectin to Glycoprofile ENhanced with Data-driven (LeGenD), a lectin and AI-based approach, to predict dominant N-glycan structures and determine their relative abundance on purified proteins based on lectin-binding patterns. We trained the LeGenD model on 309 glycoprofiles from 10 recombinant proteins, produced in 30 glycoengineered CHO cell lines. Independent test data showed that the dominant glycosylation patterns in a given protein can be effectively determined. Further analysis using SHapley Additive exPlanations helped to identify critical lectins for glycoprofile predictions. Thus, our LeGenD approach presents an alternative platform for analyzing protein glycosylation and could complement the existing toolkits used to study glycosylation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.